Arizona Bioscience News: Entrepreneurs honored; NAU expands on Phoenix Biomedical Campus; ASU, Mayo Clinic team up

December 3, 2015

By Matt Ellsworth

ASU_2NAU’s growth includes Phoenix Biomedical Campus / Flagstaff Business News

In just three years, Northern Arizona University health-professions programs have expanded their presence at the Phoenix Biomedical Campus, earned recognition for quality, and are generating a pronounced economic impact.

ASU partners with Mayo Clinic to combat Alzheimer’s, other issues facing medical industry / State Press

Arizona State University researchers will partner with Mayo Clinic in Arizona once again to conduct research on issues facing the medical industry, with a significant focus this year on Alzheimer’s disease.

Here’s how ‘bone marrow transplants’ work / Arizona Republic

Bone-marrow transplants are typically used to treat blood cancers such as leukemia, lymphoma and multiple myeloma, and in the majority of cases, the source of the stem cells to complete the transplant are taken from the bloodstream of the patient or a donor.

Arizona inspectors find Theranos lab issues / Arizona Republic

Theranos, which operates retail locations inside 40 Walgreens stores across metro Phoenix, did not always meet lab regulations before the company took corrective steps on the four issues, according to state inspection reports from earlier this year.

Angel investment tax credit a primer to Arizona’s economic engine / Phoenix Business Journal

Guest blogger Steve Zylstra, president and CEO of the Arizona Technology Council, writes that the technology council and others will ask members of the Legislature to recapitalize the angel-investment tax-credit program when they reconvene in January.

Phoenix looks to sell TGen biotech building, labs downtown / Phoenix Business Journal

The city of Phoenix is looking to sell the city-owned building that serves as the headquarters and research labs of the Translational Genomics Research Institute and International Genomics Consortium for at least $62.9 million.

Chandler pharmaceutical company sees rapid financial gains, but faces legal scrutiny over pain meds / Cronkite News

Chandler-based Insys Therapeutics Inc. is a pharmaceutical company that has exploded both in revenue and employment in recent years, yet its CEO has resigned and the company faces at least two federal and three state investigations.

St. Joseph’s Hospital steals top Alzheimer’s scientist from Banner / Phoenix Business Journal

After 15 years with Banner Sun Health Research Institute, Dr. Marwan Sabbagh has become director of the Alzheimer’s and Memory Disorders Division at Barrow Neurological Institute in Phoenix — and has taken a research grant with him for a new study that will use a one-drop blood test to study Alzheimer’s in people with Down syndrome.

Doctor: This silent killer needs loud champions / Arizona Republic

Dr. Daniel Von Hoff, a distinguished professor and physician-in-chief at TGen, writes that we have the technology and experts to fight pancreatic cancer—soon to be the second leading cause of death from cancer in the United States—but not the necessary funding.

The ‘Ones to Watch’ in Phoenix medicine / 12 News

The stories of four people in Phoenix medicine—from University of Arizona College of Medicine to Barrow Neurological Institute to Phoenix Children’s Hospital— are featured.

6 Arizona entrepreneurs honored with ASU’s Spirit of Enterprise Awards / Arizona Republic

Bioscience companies were among the annual Spirit of Enterprise Awards winners awarded by the W. P. Carey School of Business at ASU to companies that exert a positive impact on the economy while demonstrating ethics, energy and excellence.

Walking the walk in our STEM city / Flagstaff Business News

Over the past several years, our STEM City of Flagstaff has grown in stature and success, and is continually held as a model for community leadership and collective action on STEM.